| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13131* | 2021 |
| Paraneoplastic thrombocytosis in ovarian cancer RL Stone, AM Nick, IA McNeish, F Balkwill, HD Han, J Bottsford-Miller, ... New England Journal of Medicine 366 (7), 610-618, 2012 | 837 | 2012 |
| Preclinical and clinical development of siRNA-based therapeutics G Ozcan, B Ozpolat, RL Coleman, AK Sood, G Lopez-Berestein Advanced drug delivery reviews 87, 108-119, 2015 | 523 | 2015 |
| Targeting the pro-death and pro-survival functions of autophagy as novel therapeutic strategies in cancer K Dalby, I Tekedereli, G Lopez-Berestein, B Ozpolat Autophagy 6 (3), 322-329, 2010 | 510 | 2010 |
| Liposomal siRNA nanocarriers for cancer therapy B Ozpolat, AK Sood, G Lopez-Berestein Advanced drug delivery reviews 66, 110-116, 2014 | 456 | 2014 |
| Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells U Akar, A Chaves-Reyez, M Barria, A Tari, A Sanguino, Y Kondo, ... Autophagy 4 (5), 669-679, 2008 | 322 | 2008 |
| Nanomedicine based approaches for the delivery of siRNA in cancer B Ozpolat, AK Sood, G Lopez‐Berestein Journal of internal medicine 267 (1), 44-53, 2010 | 278 | 2010 |
| Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer N Hasima, B Ozpolat Cell death & disease 5 (11), e1509-e1509, 2014 | 267 | 2014 |
| Nanotechnology in cancer therapy B Aslan, B Ozpolat, AK Sood, G Lopez-Berestein Journal of drug targeting 21 (10), 904-913, 2013 | 194 | 2013 |
| Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... EBioMedicine 38, 100-112, 2018 | 177 | 2018 |
| Tissue transglutaminase inhibits autophagy in pancreatic cancer cells U Akar, B Ozpolat, K Mehta, J Fok, Y Kondo, G Lopez-Berestein Molecular Cancer Research 5 (3), 241-249, 2007 | 154 | 2007 |
| RNAi-based therapeutics and tumor targeted delivery in cancer G Kara, GA Calin, B Ozpolat Advanced drug delivery reviews 182, 114113, 2022 | 149 | 2022 |
| Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia MN Harris, B Ozpolat, F Abdi, S Gu, A Legler, KG Mawuenyega, ... Blood 104 (5), 1314-1323, 2004 | 142 | 2004 |
| Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer I Tekedereli, SN Alpay, CDJ Tavares, ZE Cobanoglu, TS Kaoud, I Sahin, ... PloS one 7 (7), e41171, 2012 | 141 | 2012 |
| Targeting autophagy in cancer management–strategies and developments B Ozpolat, DM Benbrook Cancer management and research, 291-299, 2015 | 133 | 2015 |
| Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells P Kanlikilicer, MH Rashed, R Bayraktar, R Mitra, C Ivan, B Aslan, X Zhang, ... Cancer research 76 (24), 7194-7207, 2016 | 130 | 2016 |
| Therapeutic silencing of Bcl-2 by systemically administered siRNA nanotherapeutics inhibits tumor growth by autophagy and apoptosis and enhances the efficacy of chemotherapy in … I Tekedereli, SN Alpay, U Akar, E Yuca, C Ayugo-Rodriguez, HD Han, ... Molecular Therapy-Nucleic Acids 2, 2013 | 122 | 2013 |
| MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase R Bayraktar, M Pichler, P Kanlikilicer, C Ivan, E Bayraktar, N Kahraman, ... Oncotarget 8 (7), 11641, 2017 | 121 | 2017 |
| Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers B Ozpolat, G Lopez-Berestein, P Adamson, CJ Fu, AH Williams J Pharm Pharm Sci 6 (2), 292-301, 2003 | 118 | 2003 |
| Pancreatic cancer stem cells and therapeutic approaches G Ercan, A Karlitepe, B Ozpolat Anticancer research 37 (6), 2761-2775, 2017 | 113 | 2017 |
